7 ALS Headlines You Can’t Miss

0
(0)

3 – Eisai Withdraws Application for Ultra-High Dose of Mecobalamin, a B12 Form, as ALS Treatment

Vitamin B12 and ALS

Eisai announced it has withdrawn its new drug application for an ultra-high dose Mecobalamin as a treatment for amyotrophic lateral sclerosis (ALS) in Japan, and is reviewing its next steps in consultation with Japanese regulatory officials.

Read full here: http://bit.ly/1o6v4Oh

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *